• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁酸的回肠排泄:与胆汁胆汁成分的比较及熊去氧胆酸治疗的效果

Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.

作者信息

Stiehl A, Raedsch R, Rudolph G

机构信息

Department of Medicine, University of Heidelberg, Federal Republic of Germany.

出版信息

Gastroenterology. 1988 May;94(5 Pt 1):1201-6. doi: 10.1016/0016-5085(88)90013-3.

DOI:10.1016/0016-5085(88)90013-3
PMID:3350290
Abstract

The amount of bile acid excreted via an ileostomy at the end of the ileum should give an estimate of the amount of bile acid transported to the colon. In the present study, 8 patients with ileostomies at the end of the ileum but without disease or resection of the small intestine excreted 1690 +/- 205 mumol/day (mean +/- SEM) of bile acids from the ileostomies. In comparison with duodenal bile, cholic acid was increased at the end of the ileum and chenodeoxycholic acid decreased; in addition, bile acid sulfates were increased and bile acid glucuronides were decreased. When ursodeoxycholic acid, a bile acid that decreases biliary cholesterol saturation and dissolves gallstones, was administered at a dose of 500 mg to each subject, 59% +/- 8% (mean +/- SEM) of this bile acid was excreted within 24 h from the ileostomies. It is apparent from these studies that absorption of ursodeoxycholic acid from the small intestine is slower than previously anticipated and involves the entire small intestine and probably also the colon.

摘要

经回肠末端回肠造口排出的胆汁酸量应能估算出输送至结肠的胆汁酸量。在本研究中,8名回肠末端有回肠造口但无小肠疾病或切除术的患者,回肠造口每天排出1690±205微摩尔(平均值±标准误)的胆汁酸。与十二指肠胆汁相比,回肠末端胆酸增加,鹅去氧胆酸减少;此外,胆汁酸硫酸盐增加,胆汁酸葡糖醛酸酯减少。当向每位受试者给予剂量为500毫克的熊去氧胆酸(一种可降低胆汁胆固醇饱和度并溶解胆结石的胆汁酸)时,该胆汁酸的59%±8%(平均值±标准误)在24小时内从回肠造口排出。从这些研究中可以明显看出,熊去氧胆酸在小肠的吸收比之前预期的要慢,且涉及整个小肠,可能还包括结肠。

相似文献

1
Ileal excretion of bile acids: comparison with biliary bile composition and effect of ursodeoxycholic acid treatment.胆汁酸的回肠排泄:与胆汁胆汁成分的比较及熊去氧胆酸治疗的效果
Gastroenterology. 1988 May;94(5 Pt 1):1201-6. doi: 10.1016/0016-5085(88)90013-3.
2
Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.
Gastroenterology. 1990 Feb;98(2):424-8. doi: 10.1016/0016-5085(90)90834-n.
3
Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.熊去氧胆酸或鹅去氧胆酸对人体胆汁胆固醇饱和度及胆汁酸代谢的不同影响。一项剂量反应研究。
Dig Dis Sci. 1982 Feb;27(2):161-8. doi: 10.1007/BF01311711.
4
Effect of litholytic bile acids on cholesterol absorption in gallstone patients.溶石胆汁酸对胆结石患者胆固醇吸收的影响。
Gastroenterology. 1983 Feb;84(2):265-71.
5
Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.熊去氧胆酸和鹅去氧胆酸对人体胆汁酸动力学及胆汁脂质分泌的比较效应。关于胆汁酸合成不同作用模式的证据。
Gastroenterology. 1983 Dec;85(6):1248-56.
6
Ursodeoxycholic acid ingestion after ileal resection. Effect on biliary bile acid and lipid composition.
Dig Dis Sci. 1981 Aug;26(8):705-9. doi: 10.1007/BF01316859.
7
Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.熊去氧胆酸对胆结石患者胆汁胆汁酸及胆汁脂质成分的影响。
Hepatology. 1984 Jan-Feb;4(1):107-11. doi: 10.1002/hep.1840040119.
8
Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.胆汁酸耗竭以及熊去氧胆酸和鹅去氧胆酸对仓鼠胆汁蛋白质分泌的影响。
Life Sci. 1990;46(23):1727-37. doi: 10.1016/0024-3205(90)90388-8.
9
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.熊去氧胆酸对原发性胆汁性肝硬化患者血浆和尿胆汁酸的影响
Hepatology. 1990 Sep;12(3 Pt 1):492-7. doi: 10.1002/hep.1840120308.
10
Effect of 7-ketolithocholic acid on bile acid metabolism in humans.7-酮石胆酸对人体胆汁酸代谢的影响。
Gastroenterology. 1982 Aug;83(2):341-7.

引用本文的文献

1
High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts.高脂饮食会增强并延迟熊去氧胆酸的吸收,但会提高循环中疏水性胆盐的水平。
Front Pharmacol. 2023 Apr 17;14:1168144. doi: 10.3389/fphar.2023.1168144. eCollection 2023.
2
Treatment of primary sclerosing cholangitis.原发性硬化性胆管炎的治疗
Curr Treat Options Gastroenterol. 2007 Apr;10(2):111-9. doi: 10.1007/s11938-007-0063-6.
3
Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
结肠炎和回肠储袋对原发性硬化性胆管炎中熊去氧胆酸胆汁富集的影响。
Dig Dis Sci. 2006 Mar;51(3):618-22. doi: 10.1007/s10620-006-3180-5.
4
Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.胆汁酸类似物75硒-高胆酸-牛磺酸的肠道吸收在原发性胆汁性肝硬化中增加,而在熊去氧胆酸给药期间恢复正常。
Gut. 2003 Sep;52(9):1371-5. doi: 10.1136/gut.52.9.1371.
5
Influence of cholestasis on absorption of ursodeoxycholic acid.胆汁淤积对熊去氧胆酸吸收的影响。
Dig Dis Sci. 1999 Apr;44(4):817-22. doi: 10.1023/a:1026686530785.
6
Ursodeoxycholic acid in the treatment of liver diseases.熊去氧胆酸在肝脏疾病治疗中的应用。
Postgrad Med J. 1997 Feb;73(856):75-80. doi: 10.1136/pgmj.73.856.75.
7
Clinical pharmacokinetics of therapeutic bile acids.治疗性胆汁酸的临床药代动力学
Clin Pharmacokinet. 1996 May;30(5):333-58. doi: 10.2165/00003088-199630050-00002.
8
Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.原发性胆汁性肝硬化中的胆酸和熊去氧胆酸治疗。胆汁酸模式的变化及其与肝功能的相关性。
Eur J Clin Pharmacol. 1993;45(3):221-5. doi: 10.1007/BF00315387.
9
Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.人类行结肠次全切除术或全结肠切除术后胆固醇快速成核时间与胆固醇胆结石形成
Gut. 1994 Dec;35(12):1760-4. doi: 10.1136/gut.35.12.1760.
10
Intestinal absorption of unconjugated dihydroxy bile acids: non-mediation by the carrier system involved in long chain fatty acid absorption.未结合二羟基胆汁酸的肠道吸收:不通过参与长链脂肪酸吸收的载体系统介导。
Lipids. 1990 Jan;25(1):11-6. doi: 10.1007/BF02562421.